Shareholding disclosure

Novartis AG

Declared position

4.98%

Threshold

Crossed upwards

Timeline

Published

28.01.2014

Transaction

21.01.2014

Voting rights breakdown

Voting rights acquired4.98%

Voting rights sold1.884%

Below threshold0%

Notice details

CategoryGroup of shareholders

ExchangeXSWX

Notification ID

TBE1N00040

Beneficial owner

Novartis AG

Declared address

Novartis AG, 4056 Basel

Vesting under employees participation programs

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Novartis AG

Novartis AG28.01.2014TBE1N00040

Disclosure summary

Novartis AG disclosed a holding in Novartis AG on the acquisition side, published by SIX Exchange Regulation on 28.01.2014, at 4.98% of voting rights. Notice category: Group of shareholders.

Disclosed position

4.98%

Voting rights acquired

Voting rights acquired4.98%

Voting rights sold1.884%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Novartis AG disclosed a holding in Novartis AG, published on 28.01.2014.

Publication date28.01.2014

Transaction date21.01.2014

Issuing companyNovartis AG

Beneficial ownerNovartis AG

Declared addressNovartis AG, 4056 Basel

CategoryGroup of shareholders

Voting rights acquired4.98%

Voting rights sold1.884%

Below threshold0%

ExchangeXSWX

Notification IDTBE1N00040

Commercial register

CHE-103.867.266

Registered

Zefix record

Conditions

Vesting under employees participation programs

Source: SIX Exchange Regulation · Publication date: 28.01.2014

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open